Stockreport

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study [Yahoo! Finance]

BriaCell Therapeutics Corp. - Common Shares  (BCTX) 
PDF Bria-OTS™ to be studied as monotherapy and in combination with BeiGene's anti-PD-1 antibody NCT06471673 ) to evaluate the safety and efficacy of Bria-OTS™, BriaCell's [Read more]